All News

    Global Submission Seeks Approval for Sugemalimab Treatment in NSCLC

    March 24th 2025, 9:00pm

    Article

    An application was submitted to the European Medicines Agency seeking approval for treatment with sugemalimab in stage 3 NSCLC following chemoradiotherapy.

    Dr. Sheri Prentiss on Steps for Lymphedema Screening in Breast Cancer

    March 24th 2025, 8:00pm

    Video

    Dr. Sheri Prentiss discusses what steps patients can take to ensure they're being screened for lymphedema prior to starting their breast cancer treatment.

    First Patient Dosed in Phase 3 Trial of IBI354 for Ovarian Cancer

    March 24th 2025, 7:00pm

    Article

    The first patient was dosed in a phase 3 trial of IBI354 for platinum-resistant ovarian cancer with HER2 expression.

    How Hope Erased My Fear of Testicular Cancer

    March 24th 2025, 5:09pm

    Article

    Hope helped me navigate my testicular cancer diagnosis at 20, shaping my resilience and guiding my journey as a survivor.

    Cretostimogene Has Durable Response in BCG-Unresponsive Bladder Cancer

    March 24th 2025, 4:00pm

    Article

    Cretostimogene treatment shows best-in-class durability of response for BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ

    Phase 3 Study Design Finalized with FDA for IMNN-001 in Ovarian Cancer

    March 24th 2025, 3:00pm

    Article

    The phase 3 trial design evaluating IMNN-001 in newly diagnosed advanced ovarian cancer has been finalized among regulatory agencies.

    Colorectal Cancer Awareness: Key Signs, Screening and Prevention

    March 24th 2025, 1:00pm

    Article

    Dr. Zachariah H. Foda discusses key colorectal cancer warning signs, the rise in younger diagnoses and more.

    Unraveling Disparities and Genomic Advances Across Breast Cancer Care

    March 23rd 2025, 6:00pm

    Article

    Dr. Regina Hampton shares case studies from her own practice, illustrating how genomic insights have improved patient outcomes in those with breast cancer.

    Reducing Bowel Complications Following Radiation in Prostate Cancer

    March 23rd 2025, 2:00pm

    Article

    SpaceOAR Hydrogel reduced the risk of bowel disorders, the need for colonoscopy and rectal resection following radiation therapy in prostate cancer.

    First Patients Dosed in WU-CART-007 Trial for Blood Cancer Subtypes

    March 22nd 2025, 6:00pm

    Article

    The first patients have been dosed in a trial of CAR T therapy in relapsed/refractory T cell acute lymphoblastic leukemia or T cell lymphoblastic lymphoma.